Berg M - Search Results

1

Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial.

Privitera MD, Welty TE, Gidal BE, Diaz FJ, Krebill R, Szaflarski JP, Dworetzky BA, Pollard JR, Elder EJ Jr, Jiang W, Jiang X, Berg M. Privitera MD, et al. Among authors: berg m. Lancet Neurol. 2016 Apr;15(4):365-72. doi: 10.1016/S1474-4422(16)00014-4. Epub 2016 Feb 12. Lancet Neurol. 2016. PMID: 26875743 Clinical Trial.

2

Coffee and cigarette smoking interactions with lamotrigine.

Welty TE, Gidal BE, Duan J, Privitera MD, Berg MJ, Krebill R, Szaflarski J, Diaz FJ. Welty TE, et al. Epilepsy Behav. 2021 Mar;116:107741. doi: 10.1016/j.yebeh.2020.107741. Epub 2021 Jan 22. Epilepsy Behav. 2021. PMID: 33493803

3

Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical Trial.

Berg M, Welty TE, Gidal BE, Diaz FJ, Krebill R, Szaflarski JP, Dworetzky BA, Pollard JR, Elder EJ Jr, Jiang W, Jiang X, Switzer RD, Privitera MD. Berg M, et al. JAMA Neurol. 2017 Aug 1;74(8):919-926. doi: 10.1001/jamaneurol.2017.0497. JAMA Neurol. 2017. PMID: 28654954 Free PMC article. Clinical Trial.

4

Random-effects linear modeling and sample size tables for two special crossover designs of average bioequivalence studies: the four-period, two-sequence, two-formulation and six-period, three-sequence, three-formulation designs.

Diaz FJ, Berg MJ, Krebill R, Welty T, Gidal BE, Alloway R, Privitera M. Diaz FJ, et al. Among authors: berg mj. Clin Pharmacokinet. 2013 Dec;52(12):1033-43. doi: 10.1007/s40262-013-0103-4. Clin Pharmacokinet. 2013. PMID: 24085600

5

How Do Clinicians Adjust Lamotrigine Doses and Use Lamotrigine Blood Levels?-A Q-PULSE Survey.

Privitera M, Welty T, Gidal B, Carlson C, Pollard J, Berg M. Privitera M, et al. Among authors: berg m. Epilepsy Curr. 2014 Jul;14(4):218-23. doi: 10.5698/1535-7597-14.4.218. Epilepsy Curr. 2014. PMID: 25170325 Free PMC article. No abstract available.

6

Safety and Efficacy of Natalizumab as Adjunctive Therapy for People With Drug-Resistant Epilepsy: A Phase 2 Study.

French JA, Cole AJ, Faught E, Theodore WH, Vezzani A, Liow K, Halford JJ, Armstrong R, Szaflarski JP, Hubbard S, Patel J, Chen K, Feng W, Rizzo M, Elkins J, Knafler G, Parkerson KA; OPUS Study Group. French JA, et al. Neurology. 2021 Nov 2;97(18):e1757-e1767. doi: 10.1212/WNL.0000000000012766. Epub 2021 Sep 14. Neurology. 2021. PMID: 34521687 Free PMC article. Clinical Trial.

7

Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.

Berg MJ, Gross RA, Tomaszewski KJ, Zingaro WM, Haskins LS. Berg MJ, et al. Neurology. 2008 Aug 12;71(7):525-30. doi: 10.1212/01.wnl.0000319958.37502.8e. Neurology. 2008. PMID: 18695164

8

Generic substitution in the treatment of epilepsy: patient and physician perceptions.

Berg MJ, Gross RA, Haskins LS, Zingaro WM, Tomaszewski KJ. Berg MJ, et al. Epilepsy Behav. 2008 Nov;13(4):693-9. doi: 10.1016/j.yebeh.2008.06.001. Epub 2008 Sep 10. Epilepsy Behav. 2008. PMID: 18589000

9

The place of generic modified-release formulations for epilepsy: Slow and steady.

French JA, Berg MJ. French JA, et al. Neurology. 2016 Apr 26;86(17):1572-3. doi: 10.1212/WNL.0000000000002620. Epub 2016 Mar 25. Neurology. 2016. PMID: 27016523 No abstract available.

10

Comment: Ghrelin and des-acyl ghrelin: Do they predict success of AED treatment?

Tollefson TJ, Berg MJ. Tollefson TJ, et al. Neurology. 2018 Jul 3;91(1):29. doi: 10.1212/WNL.0000000000005722. Epub 2018 May 25. Neurology. 2018. PMID: 29802170 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,147 results

Search Page